title: [Adoptive immunotherapy for cancer with genetically engineered T cells].
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ikeda
authors.forename: Sachiko
authors.initials: S
authors.lastname: Okamoto
authors.forename: Junichi
authors.initials: J
authors.lastname: Mineno
authors.forename: Naoko
authors.initials: N
authors.lastname: Imai
authors.forename: Mamoru
authors.initials: M
authors.lastname: Ito
authors.forename: Masaki
authors.initials: M
authors.lastname: Yasukawa
authors.forename: Kazuto
authors.initials: K
authors.lastname: Takesako
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shiku
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm; D018414:CD8-Positive T-Lymphocytes / Q000637:transplantation; D004195:Disease Models, Animal; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods; D051379:Mice; D009363:Neoplasm Proteins; D009369:Neoplasms / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D012190:Retroviridae
chemical_list: D000951:Antigens, Neoplasm; C095204:MAGEA4 protein, human; D009363:Neoplasm Proteins; D011948:Receptors, Antigen, T-Cell